L -Asp is a useful tool in the purification of the ionotropic glutamate receptor A2 ligand-binding domain

FEBS Journal

Volumn 281, Issue 10, 2014, Pages 2422-2430

  Krintel, Christian ^a   Frydenvang, Karla ^a   Ceravalls De Rabassa, Anna ^a   Kærn, Anne M ^a   Gajhede, Michael ^a   Pickering, Darryl S ^a   Kastrup, Jette S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

crystal structures; differential scanning fluorimetry; ionotropic glutamate receptor A2 (GluA2); l Asp; purification

Indexed keywords

ASPARTIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC GLUTAMATE RECEPTOR A2; IONOTROPIC RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CRYSTALLIZATION; DIFFERENTIAL SCANNING FLUORIMETRY; DIMERIZATION; FLUOROMETRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SUBUNIT;

CRYSTAL STRUCTURES; DIFFERENTIAL SCANNING FLUORIMETRY; IONOTROPIC GLUTAMATE RECEPTOR A2 (GLUA2); L-ASP; PURIFICATION;

ANIMALS; ASPARTIC ACID; CRYSTALLOGRAPHY, X-RAY; GLUTAMIC ACID; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, AMPA; RECOMBINANT PROTEINS;

EID: 84901245917     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12795     Document Type: Article

References (28)

1. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, &, Dingledine R, (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62, 405-496.
2. Chang PK, Verbich D, &, McKinney RA, (2012) AMPA receptors as drug targets in neurological disease-advantages, caveats, and future outlook. Eur J Neurosci 35, 1908-1916.
3. Armstrong N, &, Gouaux E, (2000) Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 28, 165-181.
4. Pøhlsgaard J, Frydenvang K, Madsen U, &, Kastrup JS, (2011) Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators. Neuropharmacology 60, 135-150.
5. Chen GQ, &, Gouaux E, (1997) Overexpression of a glutamate receptor (GluR2) ligand binding domain in Escherichia coli: application of a novel protein folding screen. Proc Natl Acad Sci USA 94, 13431-13436.
6. Chen GQ, Sun Y, Jin R, &, Gouaux E, (1998) Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct. Protein Sci 7, 2623-2630.
7. Ramanoudjame G, Du M, Mankiewicz KA, &, Jayaraman V, (2006) Allosteric mechanism in AMPA receptors: a FRET-based investigation of conformational changes. Proc Natl Acad Sci USA 103, 10473-10478.
8. Juknaite L, Venskutonyte R, Assaf Z, Faure S, Gefflaut T, Aitken DJ, Nielsen B, Gajhede M, Kastrup JS, Bunch L, et al,. (2012) Pharmacological and structural characterization of conformationally restricted (S)-glutamate analogues at ionotropic glutamate receptors. J Struct Biol 180, 39-46.
9. Ericsson UB, Hallberg BM, Detitta GT, Dekker N, &, Nordlund P, (2006) Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem 357, 289-298.
10. Niesen FH, Berglund H, &, Vedadi M, (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2, 2212-2221.
11. Frandsen A, Pickering DS, Vestergaard B, Kasper C, Nielsen BB, Greenwood JR, Campiani G, Fattorusso C, Gajhede M, Schousboe A, et al,. (2005) Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2. Mol Pharmacol 67, 703-713.
12. Bagby S, Tong KI, &, Ikura M, (2001) Optimization of protein solubility and stability for protein nuclear magnetic resonance. Methods Enzymol 339, 20-41.
13. Golovanov AP, Hautbergue GM, Wilson SA, &, Lian LY, (2004) A simple method for improving protein solubility and long-term stability. J Am Chem Soc 126, 8933-8939.
14. Juknaite L, Sugamata Y, Tokiwa K, Ishikawa Y, Takamizawa S, Eng A, Sakai R, Pickering DS, Frydenvang K, Swanson GT, et al,. (2013) Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization. J Med Chem 56, 2283-2293.
15. Jin R, Banke TG, Mayer ML, Traynelis SF, &, Gouaux E, (2003) Structural basis for partial agonist action at ionotropic glutamate receptors. Nat Neurosci 6, 803-810.
16. Rosenmund C, Stern-Bach Y, &, Stevens CF, (1998) The tetrameric structure of a glutamate receptor channel. Science 280, 1596-1599.
17. Gong XQ, Frandsen A, Lu WY, Wan Y, Zabek RL, Pickering DS, &, Bai D, (2005) d -Aspartate and NMDA, but not l -aspartate, block AMPA receptors in rat hippocampal neurons. Br J Pharmacol 145, 449-459.
18. Coquelle T, Christensen JK, Banke TG, Madsen U, Schousboe A, &, Pickering DS, (2000) Agonist discrimination between AMPA receptor subtypes. NeuroReport 11, 2643-2648.
19. Hogner A, Kastrup JS, Jin R, Liljefors T, Mayer ML, Egebjerg J, Larsen IK, &, Gouaux E, (2002) Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core. J Mol Biol 322, 93-109.
20. Battye TG, Kontogiannis L, Johnson O, Powell HR, &, Leslie AG, (2011) iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr 67, 271-281.
21. Kabsch W, (2010) Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr D Biol Crystallogr 66, 133-144.
22. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, et al,. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235-242.
23. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, &, Read RJ, (2007) Phaser crystallographic software. J Appl Crystallogr 40, 658-674.
24. Emsley P, &, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132.
25. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al,. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221.
26. Engh RA, &, Huber R, (1991) Accurate bond and angle parameters for X-ray protein-structure refinement. Acta Crystallogr A 47, 392-400.
27. Hayward S, &, Berendsen HJ, (1998) Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme. Proteins 30, 144-154.
28. Chen VB, Arendall WB III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, &, Richardson DC, (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66, 12-21.